Smoking ups risk of some renal cell cancer histological subtypes

August 17, 2015
Smoking ups risk of some renal cell cancer histological subtypes

(HealthDay)—Smoking is a risk factor for clear cell and papillary renal cell carcinoma, but not for the chromophobe subtype, according to a study published in the September issue of The Journal of Urology.

Neel H. Patel, M.D., from the State University of New York in Buffalo, and colleagues examined the correlation between smoking and subtype. Data were collected from 816 patients with nonfamilial renal cell carcinoma (705) or benign pathology (111) undergoing nephrectomy.

The researchers found that 51 percent of patients reported smoking, including 21 percent active smokers and 30 percent former smokers. Compared with benign histology, active smoking was more common with clear cell or papillary cell carcinoma (23 and 26 percent, respectively, versus 14 percent; P < 0.05 each). Active smoking was less common with chromophobe renal cell carcinoma (6 percent; P < 0.05 versus clear cell or papillary). Any history was also less common with chromophobe versus clear cell or papillary histology (26 percent versus 53 percent [P = 0.003] or 58 percent [P = 0.001]). For clear cell and papillary histologies, but not chromophobe histology, independent associations with persisted after multivariable adjustment (odds ratios, 2.2 and 2.4, respectively; both P < 0.05).

"These findings underscore distinct carcinogenic mechanisms underlying the various renal cell carcinoma subtypes," the authors write.

Explore further: Smoking adversely impacts renal cell carcinoma survival

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Smoking adversely impacts renal cell carcinoma survival

February 27, 2014
(HealthDay)—For patients with clear cell renal cell carcinoma, smoking exposure adversely impacts cancer-specific survival and increases the risk of death from another cause, according to a study published in the March ...

Statins may reduce risk of progression of renal cancer

April 23, 2014
(HealthDay)—Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.

Study clarifies best treatments for uncommon kidney cancers

May 18, 2015
A head-to-head comparison of two biologic therapies used to treat a subset of patients with advanced kidney cancers provides much-needed clarity on the preferred treatment for the first line of attack.

Limited resection generally not equivalent in stage IA NSCLC

August 9, 2015
(HealthDay)—For older patients with invasive, stage IA non-small-cell lung cancer, limited resection is generally not equivalent to lobectomy, according to a study published online Aug. 3 in the Journal of Clinical Oncology.

Chemical shift MRI helps differentiate renal cell tumors more likely to metastasize

April 19, 2013
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment ...

Recommended for you

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

Unhealthy lifestyle responsible for 45,000 predicted cases of bowel cancer in next decade

September 25, 2018
A UNSW study shows that a large proportion of bowel cancers in Australia are preventable by adopting a healthy lifestyle – particularly for men.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.